Research ArticleClinical Investigations
18F-Florbetapir PET in Patients with Frontotemporal Dementia and Alzheimer Disease
Christopher Kobylecki, Tobias Langheinrich, Rainer Hinz, Emma R.L.C. Vardy, Gavin Brown, María-Elena Martino, Cathleen Haense, Anna M. Richardson, Alexander Gerhard, Jose M. Anton-Rodriguez, Julie S. Snowden, David Neary, Michael J. Pontecorvo and Karl Herholz
Journal of Nuclear Medicine March 2015, 56 (3) 386-391; DOI: https://doi.org/10.2967/jnumed.114.147454
Christopher Kobylecki
1Institute of Brain, Behaviour and Mental Health, University of Manchester, Manchester, United Kingdom
2Cerebral Function Unit, Greater Manchester Neurosciences Centre, Salford Royal NHS Foundation Trust, Salford, United Kingdom
Tobias Langheinrich
1Institute of Brain, Behaviour and Mental Health, University of Manchester, Manchester, United Kingdom
2Cerebral Function Unit, Greater Manchester Neurosciences Centre, Salford Royal NHS Foundation Trust, Salford, United Kingdom
Rainer Hinz
1Institute of Brain, Behaviour and Mental Health, University of Manchester, Manchester, United Kingdom
Emma R.L.C. Vardy
1Institute of Brain, Behaviour and Mental Health, University of Manchester, Manchester, United Kingdom
3Institute of Neuroscience and Newcastle University Institute of Ageing, Newcastle University, Newcastle upon Tyne, United Kingdom
4Department of Older Peoples Medicine, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom
Gavin Brown
1Institute of Brain, Behaviour and Mental Health, University of Manchester, Manchester, United Kingdom
María-Elena Martino
1Institute of Brain, Behaviour and Mental Health, University of Manchester, Manchester, United Kingdom
5Unidad de Medicina y Cirugía Experimental, Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain
Cathleen Haense
6Department of Nuclear Medicine, Hannover Medical School, Hannover, Germany
Anna M. Richardson
2Cerebral Function Unit, Greater Manchester Neurosciences Centre, Salford Royal NHS Foundation Trust, Salford, United Kingdom
7Manchester Medical School, University of Manchester, Manchester, United Kingdom; and
Alexander Gerhard
1Institute of Brain, Behaviour and Mental Health, University of Manchester, Manchester, United Kingdom
2Cerebral Function Unit, Greater Manchester Neurosciences Centre, Salford Royal NHS Foundation Trust, Salford, United Kingdom
Jose M. Anton-Rodriguez
1Institute of Brain, Behaviour and Mental Health, University of Manchester, Manchester, United Kingdom
Julie S. Snowden
1Institute of Brain, Behaviour and Mental Health, University of Manchester, Manchester, United Kingdom
2Cerebral Function Unit, Greater Manchester Neurosciences Centre, Salford Royal NHS Foundation Trust, Salford, United Kingdom
David Neary
1Institute of Brain, Behaviour and Mental Health, University of Manchester, Manchester, United Kingdom
2Cerebral Function Unit, Greater Manchester Neurosciences Centre, Salford Royal NHS Foundation Trust, Salford, United Kingdom
Michael J. Pontecorvo
8Avid Radiopharmaceuticals, Philadelphia, Pennsylvania
Karl Herholz
1Institute of Brain, Behaviour and Mental Health, University of Manchester, Manchester, United Kingdom
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 56, Issue 3
March 1, 2015
18F-Florbetapir PET in Patients with Frontotemporal Dementia and Alzheimer Disease
Christopher Kobylecki, Tobias Langheinrich, Rainer Hinz, Emma R.L.C. Vardy, Gavin Brown, María-Elena Martino, Cathleen Haense, Anna M. Richardson, Alexander Gerhard, Jose M. Anton-Rodriguez, Julie S. Snowden, David Neary, Michael J. Pontecorvo, Karl Herholz
Journal of Nuclear Medicine Mar 2015, 56 (3) 386-391; DOI: 10.2967/jnumed.114.147454
18F-Florbetapir PET in Patients with Frontotemporal Dementia and Alzheimer Disease
Christopher Kobylecki, Tobias Langheinrich, Rainer Hinz, Emma R.L.C. Vardy, Gavin Brown, María-Elena Martino, Cathleen Haense, Anna M. Richardson, Alexander Gerhard, Jose M. Anton-Rodriguez, Julie S. Snowden, David Neary, Michael J. Pontecorvo, Karl Herholz
Journal of Nuclear Medicine Mar 2015, 56 (3) 386-391; DOI: 10.2967/jnumed.114.147454
Jump to section
Related Articles
Cited By...
- Traumatic brain injury and Alzheimers Disease biomarkers: A systematic review of findings from amyloid and tau positron emission tomography (PET)
- Amyloid-PET-Positive Patient With bvFTD: Wrong Diagnosis, False Positive Scan, or Copathology?
- Derivation and utility of an A{beta}-PET pathology accumulation index to estimate A{beta} load
- Current Status of 18F-FDG PET Brain Imaging in Patients with Dementia
- Relationship of Area of Soft Drusen in Retina with Cerebral Amyloid-{beta} Accumulation and Blood Amyloid-{beta} Level in the Elderly
- Diagnostic Accuracy of MRI and Additional [18F]FDG-PET for Behavioral Variant Frontotemporal Dementia in Patients with Late Onset Behavioral Changes
- Alzheimer Disease: Approaches to Early Diagnosis and High-Accuracy Imaging
- Amyloid Imaging in Dementia: Contribution or Confusion?